TUBERCULOSIS AND ITS ASSOCIATION WITH CD4+T CELL COUNT AND VIRAL LOAD AMONG HIV POSITIVE PATIENTS IN A TERTIARY CARE HOSPITAL
DOI:
https://doi.org/10.22159/ijcpr.2024v16i4.5042Keywords:
Antiretroviral therapy, Mycobacterium tuberculosis, People living with HIV, Immunosuppression, Protease inhibitorsAbstract
Methods: The present study was a prospective study conducted from April 2022 to March 2023 in 4551 patients. Samples of 238 patients newly diagnosed with HIV attending Integrated Counselling and Testing Centre (ICTC), Visakhapatnam, Andhra Pradesh, India and registered for Antiretroviral Therapy (ART) were taken. 5 ml of blood sample was collected aseptically and tested for HIV. The 238 HIV-positive samples were tested for CD4 counts at presentation and after 6 mo using flow cytometry (Sysmex Partec CyFlow Flow cytometer). They were further subjected to real-time RT-PCR to detect viral load at 6 mo follow-up.
Results: Out of 238 HIV-positive cases, predominant gender being males with 140 (58.82%) and the predominant age group was 31-40 y. At 6 mo follow-up, 19 patients (8%) were diagnosed as having TB. The mean CD4 counts at baseline and after 6 mo of antiretroviral therapy (ART)) was 296±229 and 436±271 cells/mm3 (p value of<0.001) for entire study group. The mean baseline CD4 count in patients who were not diagnosed with TB at the time of follow-up and those who were diagnosed as having developed TB was 307±232 cells/mm3 and 167±135 cells/mm3 respectively. At six mo follow-up, 32(14.6%) HIV patients who did not develop TB and 8(42.1%) patients who developed TB still had their CD4 counts<200 cells/mm3. This was statistically significant with a p value=0.019. Significant difference was not found between the two subgroups as the HIV-only group had 192(87.7%) patients and 16(84.2%) patients from newly diagnosed TB patients had their viral loads below detection levels.
Conclusion: low CD4 counts at the baseline was a high-risk factor for the development of tuberculosis in HIV patients. The viral load values at 6-month follow-up did not prove to be significantly linked to the development of tuberculosis.
Downloads
References
Aaron L, Saadoun D, Calatroni I, Launay O, Memain N, Vincent V. Tuberculosis in HIV-infected patients: a comprehensive review. Clin Microbiol Infect. 2004;10(5):388-98. doi: 10.1111/j.1469-0691.2004.00758.x, PMID 15113314.
Global tuberculosis report; 2023. p. 2.
Whalen C, Horsburgh CR, Hom D, lahart C, Simberkoff M, Ellner J. Accelerated course of human immunodeficiency virus infection after tuberculosis. Am J Respir Crit Care Med. 1995 Jan;151(1):129-35. doi: 10.1164/ajrccm.151.1.7812542, PMID 7812542.
Gupte AN, Kadam D, Sangle S, Rewari BB, Salvi S, Chavan A. Incidence of tuberculosis in HIV-infected adults on first- and second-line antiretroviral therapy in India. BMC Infect Dis. 2019 Oct 29;19(1):914. doi: 10.1186/s12879-019-4569-z, PMID 31664933.
Narita M, Ashkin D, Hollender ES, Pitchenik AE. Paradoxical worsening of tuberculosis following antiretroviral therapy in patients with AIDS. Am J Respir Crit Care Med. 1998;158(1):157-61. doi: 10.1164/ajrccm.158.1.9712001, PMID 9655723.
Hamada Y, Getahun H, Tadesse BT, Ford N. HIV-associated tuberculosis. Int J STD AIDS. 2021;32(9):780-90. doi: 10.1177/0956462421992257, PMID 33612015.
Awadalla H, El-Samani F, Soghaier MA, Makki M. Risk factors associated with the development of tuberculosis among HIV-infected patients in Khartoum in 2010. AIMS Public Health. 2015 Dec 2;2(4):784-92. doi: 10.3934/publichealth.2015.4.784, PMID 29546135.
Geremew D, Melku M, Endalamaw A, Woldu B, Fasil A, Negash M. Tuberculosis and its association with CD4+T cell count among adult HIV positive patients in Ethiopian settings: a systematic review and meta-analysis. BMC Infect Dis. 2020 May 7;20(1):325. doi: 10.1186/s12879-020-05040-4, PMID 32380957.
Cassenote AJ, Grangeiro A, Escuder MM, Abe JM, Segurado AA. Validation of CD4+T-cell and viral load data from the HIV-brazil cohort study using secondary system data. BMC Infect Dis. 2018;18(1):617. doi: 10.1186/s12879-018-3536-4, PMID 30514215.
Aggarwal AN, Agarwal R, Sehgal IS, Dhooria S. Adenosine deaminase for diagnosis of tuberculous pleural effusion: a systematic review and meta-analysis. Plos One. 2019;14(3):e0213728. doi: 10.1371/journal.pone.0213728, PMID 30913213.
Winter JR, Adamu AL, Gupta RK, Stagg HR, Delpech V, Abubakar I. Tuberculosis infection and disease in people living with HIV in countries with low tuberculosis incidence. Int J Tuberc Lung Dis. 2018 Jul 1;22(7):713-22. doi: 10.5588/ijtld.17.0672, PMID 29914596.
National guidelines for HIV care and Treatment; 2021.
Jin CZ, Zhao Y, Zhang FJ, Yao HP, Wu LJ, Zhao HX. Different plasma levels of interleukins and chemokines: comparison between children and adults with AIDS in China. Chin Med J (Engl). 2009 Mar 5;122(5):530-5. PMID 19323903.
Hermans S, Horsburgh CR Jr, Wood R. A century of tuberculosis epidemiology in the northern and Southern Hemisphere: the differential impact of control interventions. Plos One. 2015 Aug 19;10(8):e0135179. doi: 10.1371/journal.pone.0135179, PMID 26288079.
Perlman DC, El-Sadr WM, Nelson ET, Matts JP, Telzak EE, Salomon N. Variation of chest radiographic patterns in pulmonary tuberculosis by degree of human immunodeficiency virus-related immunosuppression. The Terry Beirn Community programs for clinical research on AIDS (CPCRA). The AIDS Clinical Trials Group (ACTG). Clin Infect Dis. 1997;25(2):242-6. doi: 10.1086/514546, PMID 9332519.
Wondmeneh TG, Mekonnen AT. The incidence rate of tuberculosis and its associated factors among HIV-positive persons in sub-Saharan Africa: a systematic review and meta-analysis. BMC Infect Dis. 2023 Sep 18;23(1):613. doi: 10.1186/s12879-023-08533-0, PMID 37723415.
Tchakounte Youngui B, Coffie P, Messou E, Poda A, Fortes Deguenonvo l, Hawerlander D, Minga A, Balestre E, Dabis F, Marcy O. Incidence of tuberculosis during the first year of antiretroviral treatment in West African HIV-infected adults. Open Forum Infect Dis. 2020 Jun 2;7(6).
Darraj MA, Abdulhaq AA, Yassin A, Mubarki S, Shalaby HM, Keynan Y. Tuberculosis among people living with HIV/AIDS in Jazan Region, Southwestern Saudi Arabia. J Infect Public Health. 2021;14(11):1571-7. doi: 10.1016/j.jiph.2021.09.009, PMID 34656963.
Iroezindu MO, Ofondu EO, Mbata GC, van Wyk B, Hausler HP, Dh A. Factors associated with prevalent tuberculosis among patients receiving highly active antiretroviral therapy in a Nigerian tertiary hospital. Ann Med Health Sci Res. 2016 Mar-Apr;6(2):120-8. doi: 10.4103/2141-9248.181837, PMID 27213096.
Shivakoti R, Sharma D, Mamoon G, Pham K. Association of HIV infection with extrapulmonary tuberculosis: a systematic review. Infection. 2017 Feb;45(1):11-21. doi: 10.1007/s15010-016-0960-5, PMID 27830524.
Mrudula ND, Suwarna UP, Khadse R, Minal P, Shubhangi DK. Statistical analysis and evaluation of CD4 count after 6 mo on ART. Indian J Community Med. 2012 Oct;37(4):266-7. doi: 10.4103/0970-0218.103480, PMID 23293446.
Gautam H, Bhalla P, Saini S, Dewan R. Correlation between baseline CD4 +T-Lymphocyte count and plasma viral load in AIDS patients and their early clinical and immunological response to HAART: a preliminary study. Indian J Med Microbiol. 2008;26(3):256-8. doi: 10.4103/0255-0857.42039, PMID 18695327.
Chakraborty H, Iyer M, Duffus WA, Samantapudi AV, Albrecht H, Weissman S. Disparities in viral load and CD4 count trends among HIV-infected adults in South Carolina. AIDS Patient Care STDs. 2015;29(1):26-32. doi: 10.1089/apc.2014.0158, PMID 25458918.
Liu E, Makubi A, Drain P, Spiegelman D, Sando D, Li N. Tuberculosis incidence rate and risk factors among HIV-infected adults with access to antiretroviral therapy. AIDS. 2015 Jul 17;29(11):1391-9. doi: 10.1097/QAD.0000000000000705, PMID 26091295.
Published
How to Cite
Issue
Section
Copyright (c) 2024 NIGEL JOSE, ARUNA BULA, POOSAPATI RATNA KUMARI, PUVVULA KAMALA
This work is licensed under a Creative Commons Attribution 4.0 International License.
